Hathaway et al developed an index to identify renal transplant patients at risk for development of new onset diabetes mellitus following the transplant. Development of diabetes mellitus is a significant complication of the transplant that can affect quality of life, rehabilitation and infection risk. A high risk for developing new onset diabetes could affect the choice of immunosuppression regimen used. The authors are from the University of Memphis in Tennessee.
